Rare diseases
Investigational molecules
Locations
Back to Austria286 clinical trials in Salzburg, Austria across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
AustriaMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
AustriaEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
AustriaEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
AustriaFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
AustriaPhase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma
AustriaLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
AustriaA study to evaluate the safety and effectiveness of dalbavancin in patients with erysipelas or limited cellulitis being treated at home.
AustriaComparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.
AustriaA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
AustriaA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
AustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on metastatic cancers and innovative treatment approaches, including trials investigating new therapies for prostate cancer, colorectal cancer, and bladder cancer.
Multiple clinical trials evaluating targeted therapies and combination treatments for various stages of cancer progression.
Investigating breakthrough treatments for multiple myeloma and acute myeloid leukemia, with emphasis on innovative therapeutic combinations and targeted approaches.
Focus on improving outcomes for patients with various blood disorders through advanced therapeutic strategies.
Research initiatives addressing cardiovascular disease, Crohn's disease, and Alzheimer's disease, exploring new treatment modalities and therapeutic approaches.
Comprehensive studies aimed at developing more effective treatments for chronic conditions affecting quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
